Blog
About

4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intravitreal Ziv-Aflibercept for Diabetic Macular Edema: 48-Week Outcomes.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To study the safety and efficacy of intravitreal injections of ziv-aflibercept (IVI-ZA) (Zaltrap; Sanofi-Aventis and Regeneron Pharmaceuticals, Tarrytown, NY) during a period of 48 weeks in patients with diabetic macular edema (DME).

          Related collections

          Author and article information

          Journal
          Ophthalmic Surg Lasers Imaging Retina
          Ophthalmic surgery, lasers & imaging retina
          SLACK, Inc.
          2325-8179
          2325-8160
          Apr 01 2018
          : 49
          : 4
          Article
          10.3928/23258160-20180329-06
          29664981

          Comments

          Comment on this article